HOXC6: A Potential Drug Target for Cancer and Neurodegenerative Diseases

Target Name: HOXC6

NCBI ID: G3223

HOXC6

HOXC6: A Potential Drug Target for Cancer and Neurodegenerative Diseases

HOXC6, also known as HOXC6 variant 1, is a protein that is expressed in a variety of tissues throughout the body. It is a transcription factor that plays a role in the development and maintenance of tissues, including blood vessels, neurons, and epithelial cells.

HOXC6 is a key regulator of the cell cycle, which is the process by which cells grow, divide, and replicate their genetic material. It helps to control the length of the cell cycle by regulating the activity of theCDK2 kinase, which is responsible for regulating the movement of DNA through the cell nucleus.

HOXC6 is also involved in the regulation of cell apoptosis, which is the process by which cells die when they are no longer needed. It helps to ensure that cells are properly programmed to die when they are no longer able to repair themselves, which helps to prevent the buildup of harmful mutations that can lead to cancer.

HOXC6 is a transcription factor that has been shown to be involved in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. It is also a potential drug target, which means that it may be a target for future scientific research and clinical trials.

One of the main reasons why HOXC6 is a potential drug target is because it is involved in so many different processes in the body. This makes it difficult to identify potential drug targets, but it also means that there is potential for targeting multiple mechanisms of action.

HOXC6 is involved in the regulation of the cell cycle, which is a critical process for the development and maintenance of tissues. It is also involved in the regulation of cell apoptosis, which helps to ensure that cells are properly programmed to die when they are no longer needed.

HOXC6 is a transcription factor that plays a key role in the regulation of the cell cycle and cell apoptosis. It is a potential drug target, which means that it may be a target for future scientific research and clinical trials. Further studies are needed to determine the full extent of HOXC6's involvement in these processes and to identify potential drug targets.

Protein Name: Homeobox C6

Functions: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis

The "HOXC6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXC6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets